LQTS: Difference between revisions

Jump to navigation Jump to search
297 bytes added ,  25 March 2013
m
no edit summary
mNo edit summary
 
Line 310: Line 310:
===Medication/Other therapies:===  
===Medication/Other therapies:===  
*Beta-blockers are the cornerstone of therapy in LQTS. Beta-blockers even reduce the risk of sudden death in patients in whom a genetic defect has been found, but no QT prolon
*Beta-blockers are the cornerstone of therapy in LQTS. Beta-blockers even reduce the risk of sudden death in patients in whom a genetic defect has been found, but no QT prolon
==References==
<biblio>
#Schwartz2001 pmid=11136691
#Alders pmid=20301308
#adenosine pmid=16105845
#priori pmid=12736279
#Adler pmid=22300664
#Shimizu2009 pmid=19926013
#Moss pmid=17470695
#Sy pmid=22042885
#Schwartz2011 pmid=22083145
#Viskin pmid=20116193
#Shimizu2004 pmid=15851169
</biblio>

Navigation menu